Şunu aradınız:: efmoroctocog (İngilizce - İzlandaca)

powder: 1000 iu efmoroctocog alfa (approx.
stofn: 1000 iu efmoroctocog alfa (u.þ.b.

each vial contains nominally 1500 iu efmoroctocog alfa.
hvert hettuglas inniheldur 1500 iu af efmoroctocog alfa.

efmoroctocog alfa (recombinant coagulation factor viii)
efmoroctocog alfa (raðbrigða storkuþáttur viii)

efmoroctocog alfa recombinant coagulation factor viii, fc fusion protein
efmoroctocog alfa raðbrigða storkuþáttur viii, fc samrunaprótín

elocta contains the active substance efmoroctocog alfa, a recombinant coagulation factor viii, fc fusion protein.
elocta inniheldur virka innihaldsefnið efmoroctocog alfa, raðbrigða storkuþátt viii, fc samrunaprótín.

each vial of elocta contains nominally 250, 500, 750, 1000, 1500, 2000 or 3000 iu efmoroctocog alfa.
hvert hettuglas af elocta inniheldur 250, 500, 750, 1000, 1500, 2000 eða 3000 iu af efmoroctocog alfa.

efmoroctocog alfa binds to neonatal fc receptor thereby utilising this same naturally occurring pathway to delay lysosomal degradation and allow for longer plasma half-life than endogenous factor viii.
efmoroctocog alfa binst fc viðtaka nýbura og notar því sömu náttúrulegu leið til þess að seinka niðurbroti í leysikornum og veita lengri helmingunartíma í blóðvökva en innrænn þáttur viii.